全球生育補充劑市場規模、佔有率、成長分析，依最終用途（男性和女性）、配銷通路（非處方藥和處方藥）- 2024-2031 年行業預測

Global Fertility Supplements Market Size, Share, Growth Analysis, By End-Use(Men, and Women), By Distribution Channel(OTC, and Prescribed) - Industry Forecast 2024-2031

出版日期: 2024年04月11日 | 出版商:

SkyQuest | 英文 198 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年，全球生育補充劑市場規模為19.4億美元，預計將從2023年的21.0億美元成長到2031年的38.8億美元，在預測期（2024-2031年）複合年成長率為8%。

生育藥產業的存在是為了給人們一種不同的方式來增強生殖健康並提高懷孕的機會。推動生育補充劑市場的主要因素之一是不孕症發病率的上升。由於消費者越來越了解使用膳食補充劑來增強生殖健康的優勢以及這些補充劑的非處方藥可及性，該市場正在不斷擴大。阻礙生育補充劑市場的一大障礙是缺乏監管和產品品質參差不齊。此外，由於成本高昂，有些人可能無法獲得某些補充劑。缺乏科學證據證明這些補充劑具有提高生育能力的能力是生育補充劑市場面臨的主要障礙之一。此外，不孕不育的恥辱和一些人不願意尋求治療可能會影響市場的成長。預計電子商務平台的日益普及和生育補充劑種類的增加將帶來新的市場前景。此外，客製化營養的日益普及以及新穎商品和配方的創造可能會推動市場擴張。在未來幾年，隨著越來越多的人尋求非傳統方法來增強生殖健康，預計全球生育補充品市場將進一步擴大。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

TTK HealthCare (India)
Fairhaven Health LLC (US)
Zenith Nutritions (India)
INVO Bioscience (US)
Vitabiotics Ltd (UK)
Bionova Lifesciences (India)
Exeltis USA Inc. (US)
Fujifilm Irvine Scientific, Inc. (US)
Coast Science (US)
Orthomol (Germany)
Theralogix LLC (US)
Mira (US)
Proxeed Plus (US)
Fertility Nutraceuticals LLC (US)
Fertility Focus Limited (UK)
DCC plc (Ireland)
Purelife Bioscience Co. Ltd. (Taiwan)
Fertility Smart (Australia)
Concepta Diagnostics (UK)
TTK Prestige Ltd (India)

簡介目錄

Product Code: SQMIG30I2247

Global Fertility Supplements Market size was valued at USD 1.94 billion in 2022 and is poised to grow from USD 2.10 billion in 2023 to USD 3.88 billion by 2031, growing at a CAGR of 8% during the forecast period (2024-2031).

The industry for fertility pills exists to give people a different way to enhance their reproductive health and boost their chances of getting pregnant. One of the main factors propelling the fertility supplement market is the rising incidence of infertility. The market is expanding as a result of growing consumer knowledge of the advantages of using dietary supplements to enhance reproductive health as well as the accessibility of these supplements over-the-counter. One major obstacle impeding the fertility supplement market is the absence of regulatory supervision and uneven product quality. In addition, some people may not be able to access some supplements due to their high cost. The absence of scientific proof demonstrating these supplements' ability to increase fertility is one of the major obstacles facing the market for fertility supplements. Furthermore, the stigma attached to infertility and some people's unwillingness to seek treatment could have an effect on the market's growth. It is anticipated that new market prospects would arise from the growing use of e-commerce platforms and the availability of a greater variety of fertility supplements. Furthermore, the growing popularity of customized nutrition and the creation of novel goods and formulas could propel market expansion. In the upcoming years, it is anticipated that the global market for fertility supplements would expand further as more people look for non-traditional ways to enhance their reproductive health.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fertility Supplements Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fertility Supplements Market Segmental Analysis

The global fertility supplements market is segmented on the basis of product, application, and region. By end-use, the market is bifurcated into men, and women. In terms of distribution channel, the market is segmented into OTC, and prescribed. By region, the market is widespread into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Fertility Supplements Market

The market for fertility supplements is mostly driven by the increased incidence of infertility in both men and women. The CDC reports that infertility affects approximately 15% of couples worldwide, and the number is rising. Because they provide a safe and affordable substitute for traditional fertility therapies, this has resulted in an increase in demand for fertility supplements.

Restraints in the Global Fertility Supplements Market

Despite the growing acceptance of fertility supplements, there is insufficient scientific data to substantiate their efficacy. Many of the manufacturer's claims are not supported by thorough clinical trials or studies, which has caused some customers and healthcare experts to be skeptical.

Market Trends of the Global Fertility Supplements Market

Consumers are increasingly opting for natural and organic fertility supplements as they are perceived to be safer and have fewer side effects. These supplements are made from natural ingredients such as herbs, vitamins, and minerals, and do not contain any synthetic substances. For instance, In folic, a natural supplement made from myo-inositol and folic acid, has gained popularity in the market due to its natural composition and effectiveness in promoting fertility.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Fertility Supplements Market by End-Use

Market Overview
Men
and Women

Global Fertility Supplements Market by Distribution Channel

Market Overview
OTC
and Prescribed

Global Fertility Supplements Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

TTK HealthCare (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fairhaven Health LLC (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zenith Nutritions (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
INVO Bioscience (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitabiotics Ltd (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bionova Lifesciences (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Exeltis USA Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Irvine Scientific, Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Coast Science (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthomol (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Theralogix LLC (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mira (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Proxeed Plus (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fertility Nutraceuticals LLC (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fertility Focus Limited (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DCC plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Purelife Bioscience Co. Ltd. (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fertility Smart (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Concepta Diagnostics (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TTK Prestige Ltd (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments